Longfang Chen

Number 197 Ruijin Second Road
Shanghai, 200025, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease-Like Autoinflammatory Syndrome.

A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease-Like Autoinflammatory Syndrome.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: October 12, 2025

Exploring rituximab efficacy in systemic lupus erythematosus with pulmonary hemorrhage: a retrospective case series from a single center.

Exploring rituximab efficacy in systemic lupus erythematosus with pulmonary hemorrhage: a retrospective case series from a single center.

Journal: Clinical rheumatology

Published: March 29, 2025

Correction: Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Correction: Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Journal: BMC medicine

Published: October 15, 2024

TLR9 decreases FOXO3 expression to prevent excessive inflammation in macrophage activation syndrome.

TLR9 decreases FOXO3 expression to prevent excessive inflammation in macrophage activation syndrome.

Journal: iScience

Published: April 25, 2024

Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome.

Ruxolitinib targets JAK-STAT signaling to modulate neutrophil activation in refractory macrophage activation syndrome.

Journal: Blood

Published: February 20, 2024

Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.

Neutrophil activation biomarker pentraxin 3 for diagnosis and monitoring of macrophage activation syndrome occurrence in adult-onset Still's disease.

Journal: Journal of autoimmunity

Published: November 10, 2023

Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Neutrophil extracellular trap-induced intermediate monocytes trigger macrophage activation syndrome in adult-onset Still's disease.

Journal: BMC medicine

Published: August 07, 2023

The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still's disease.

The landscape of innate and adaptive immune cell subsets in patients with adult-onset Still's disease.

Journal: Rheumatology (Oxford, England)

Published: June 06, 2023

Neutralizing anti-IFN-γ IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.

Neutralizing anti-IFN-γ IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.

Journal: Clinical rheumatology

Published: March 15, 2023

Cogan syndrome following SARS-COV-2 infection.

Cogan syndrome following SARS-COV-2 infection.

Journal: Clinical rheumatology

Published: March 13, 2023

Inactivated SARS-CoV-2 vaccine does not increase the risk of relapse in patients with clinically inactive adult-onset Still's disease.

Inactivated SARS-CoV-2 vaccine does not increase the risk of relapse in patients with clinically inactive adult-onset Still's disease.

Journal: Rheumatology (Oxford, England)

Published: August 11, 2022

COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study.

COVID-19 vaccine affects neither prothrombotic antibody profile nor thrombosis in primary anti-phospholipid syndrome: a prospective study.

Journal: Rheumatology (Oxford, England)

Published: May 18, 2022

Showing 1-12 of 12

Last Updated: 09/26/2026